Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

TMO A A DGX Macroaxis 15 Beers Apparel Restaurants 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Processing. Please wait...

Genomic Z Score

 
 Companies |  Insiders  | Dashboard  
     
Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in late 1960s at New York University..

Genomic

Z Score

=

Sum Of

5 Factors

=
-0.401
First Factor
=
1.2 * (
Working Capital
/
Total Assets )
Second Factor
=
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
=
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
=
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
=
0.99 * (
Revenue
/
Total Assets )
To calculate Z-Score one would need to know current working capital of the company, its total assets and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1 indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare Genomic to competition

Genomic Z Score Assessment

Genomic Health Inc has Z Score of -0.401. This is 100.08% lower than that of Healthcare sector, and 100.03% lower than that of Medical Laboratories and Research industry, The Z Score for all stocks is 100.09% higher than the company.

Filter other Stocks by Z Score

Select Z Score Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Genomic is currently under evaluation in z score category among related companies.
Follow Genomic Z Score with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Genomic to your reader
 
    
GHDX United States Nasdaq
Genomic Health Inc
Benchmark S&P 500
Currency: USD - US Dollar
Traded on NASDAQ
    
    

Other Genomic Fundamentals

Return On Equity5.21 %
Return On Asset2.75 %
Profit Margin2.75 %
Operating Margin2.78 %
Current Valuation1.02 B
Shares Outstanding30.22 M
Shares Owned by Insiders52.63 %
Shares Owned by Institutions45.70 %
Number of Shares Shorted2.5 M
Price to Earning171.91 times
Price to Book8.64 times
Price to Sales4.71 times
Revenue239.8 M
Gross Profit198.16 M
EBITDA12.15 M
Net Income6.59 M
Cash and Equivalents96.08 M
Cash per Share3.18 times
Current Ratio5.41 times
Book Value Per Share4.32 times
Cash Flow from Operations22.15 M
Short Ratio16.40 times
One Year High37.85
One Year Low25.25
Earnings Per Share0.22 times
Price to Earnings To Growth(22.69) times
Number of Employees612
Beta0.34
Market Capitalization1.12 B
Total Asset157 M
Retained Earnings(158.4 M)
Working Capital108.13 M
Current Asset132.64 M
Current Liabilities24.51 M
Z Score-0.401
Probability Of Bankruptcy64.81 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium